Apotheken
|
Doctor
|
Drugs
|
Hospital
|
Interactions
|
MiGeL
|
Registration owner
|
Services
Home
<
List for "L02BA" (19)
–
Sort according to Concentration, Size and Price
Price comparison
Price comparison and Component
Brand name
Component
Registration owner
Indication
Interaction
Unwanted Effect
Swissmedic-# (5-digit)
Pharmacode
Product
Package Size
EFP
CP
SB
DC
Composition
Registr. Holder
Category
Tamoxifen (L02BA01) 8 products
WHO-DDD
DrugBank.ca
IP
CI
Tamec 20 mg
-
T
30 Tablet(s)
11.38
28.80
10 %
Coated tablets: Tamoxifenum 20 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Tamec 20 mg
-
T
100 Tablet(s)
32.63
51.90
10 %
Coated tablets: Tamoxifenum 20 mg
Sandoz
Pharmaceuticals AG
A / SL / SG
FB
G
IP
CI
Tamoxifen Farmos 10 mg
30 Tablet(s)
6.52
16.30
10 %
Tablets: Tamoxifenum 10 mg
Orion Pharma AG
A / SL / SG
FB
G
IP
CI
Tamoxifen Farmos 10 mg
100 Tablet(s)
19.99
38.15
10 %
Tablets: Tamoxifenum 10 mg
Orion Pharma AG
A / SL / SG
FB
G
IP
CI
Tamoxifen Farmos 20 mg
30 Tablet(s)
11.38
28.80
10 %
Tablets: Tamoxifenum 20 mg
Orion Pharma AG
A / SL / SG
FB
G
IP
CI
Tamoxifen Farmos 20 mg
100 Tablet(s)
32.63
51.90
10 %
Tablets: Tamoxifenum 20 mg
Orion Pharma AG
A / SL / SG
FB
G
IP
CI
Nolvadex 20 mg
30 Tablet(s)
13.38
27.65
k.A.
Coated tablets: Tamoxifenum 20 mg
AstraZeneca AG
A
FB
G
IP
CI
Nolvadex 20 mg
100 Tablet(s)
36.26
58.05
k.A.
Coated tablets: Tamoxifenum 20 mg
AstraZeneca AG
A
FB
G
Fulvestrant (L02BA03) 9 products
WHO-DDD
DrugBank.ca
L
SIP
IP
Faslodex
2 syringe(s)
329.81
379.80
10 %
Injection solution: Fulvestrantum 250mg / 5ml
AstraZeneca AG
B / SL / SO
FB
G
L
IP
Ambiful 250 mg/5 ml
2
421.32
473.70
10 %
Injection solution in prefilled syringe: Fulvestrantum 50 mg/ml
Curatis AG
B / SL / SG
FB
G
L
IP
Fulvestrant Accord 250
mg/5 ml
2
421.32
473.70
10 %
Injection solution in prefilled syringe: Fulvestrantum 250mg / 5ml
Accord Healthcare AG
B / SL / SG
FB
G
L
IP
Fulvestrant Sandoz 250
mg/5 ml
2 Fertigspritze(n)
421.32
473.70
10 %
Injection solution in prefilled syringe: Fulvestrantum 250mg / 5ml
Sandoz
Pharmaceuticals AG
B / SL / SG
FB
G
L
IP
Fulvestrant Zentiva 250
mg/5 ml
2
421.27
473.65
10 %
Injection solution in prefilled syringe: Fulvestrantum 250mg / 5ml
Helvepharm AG
B / SL / SG
FB
G
L
IP
Fulvestrant-Teva
250mg/5ml
2
421.31
473.70
10 %
Injection solution in prefilled syringe: Fulvestrantum 250mg / 5ml
Teva Pharma AG
B / SL / SG
FB
G
IP
Fulvestrant Accord 250
mg/5 ml
PR
PR
k.A.
Injection solution in prefilled syringe: Fulvestrantum 250mg / 5ml
Accord Healthcare AG
B
FB
G
IP
Fulvestrant-Teva
250mg/5ml
PR
PR
k.A.
Injection solution in prefilled syringe: Fulvestrantum 250mg / 5ml
Teva Pharma AG
B
FB
G
Fulvestrant Labatec 250
mg/5 ml
2
PR
PR
k.A.
Solution pour injection en seringue pré-remplie: Fulvestrantum 250mg / 5ml
Labatec Pharma SA
B
FB
G
Elacestrant (L02BA04) 2 products
WHO-DDD
IP
CI
Orserdu 86 mg
28
PR
PR
k.A.
Coated tablets: Elacestrantum 86 mg
Stemline Therapeutics
Switzerland GmbH
B
FB
G
IP
Orserdu 345 mg
28
PR
PR
k.A.
Coated tablets: Elacestrantum 345 mg
Stemline Therapeutics
Switzerland GmbH
B
FB
G
show caption
Red = Original
CM
= Co-Marketing
EFP = Ex-Factory-Price, exkl. VAT CHF
Green = Generic Drug
V/S
= vaccine/blood product
CP = Consumer Price, inkl. VAT CHF
Black = not classified
A
= Anesthetic
PR = Price request
Gray background = Pending Permission Extension
SIP
= Short Information for Professionals
SB = Selbstbehalt
H
= Homeopathics
IP
= Information for Professionals
DC = Daily Cost
A
= Anthroposophics
CI
= Consumer Information
SL = Official reimbursement list of Switzerland.
Ph
= Phytotherapeutics
L
= Limitations
SO = Original according to SL
Cas Reg.Nr. = CAS Registry
G
= Google Search by Product Name
SG = Generic according to SL
P
= Import parallel
FB
= Drugs Feedback
LPPA = Liste des produits pharmaceutiques pour application spéciale
Legal Disclaimer
ATC-Browser
|
Drugs A-Z
|
Recent Registrations
2025
©ywesee GmbH
Settings
|
Help
|
FAQ
|
Login
|
Contact
|
Home
